Abbott Reports Strong Q2 2026 Sales and Raises EPS Guidance
Abbott reported 13% sales growth and significantly raised its adjusted EPS guidance. The company reaffirmed its sales outlook as it returned $2.1 billion to shareholders.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day